Organizational Chart
Departmental Flow Chart
Coordinating Committee
Advisory Board
COORDINATING COMMITTEE
The CBB Coordinating Committee is composed of representatives from eight university departments. It is the primary policy-making group of the CBB and meets regularly to discuss and advise on budgets as well as research and educational programs. CBB members in their respective departments elect representatives of the Coordinating Committee annually and they may serve a three-year period or more.
| Current CBB Coordinating Committee | |
| Faculty Member | Department |
| Charles Brenner, Ph.D. | Biochemistry |
| Alex Horswell, Ph.D. | Microbiology |
| Robert Kerns, Ph.D. | Medicinal & Natural Products Chemistry |
| Amnon Kohen, Ph.D. | Chemistry |
| Tim Mattes, Ph.D. | Civil & Environmental Engineering |
| Eric Nuxoll, Ph.D. | Chemical & Biochemical Engineering |
| Tonya Peeples, Ph.D. | Chemical & Biochemical Engineering |
| Dan Quinn, Ph.D. | Chemistry |
| Mani Subramanian, Ph.D. | Chemical & Biochemical Engineering |
ADVISORY BOARD
The CBB Advisory Board consists of distinguished academic and industrial scientists representing agrochemical, pharmaceutical, chemical and biotechnology industry. Board members attend the annual CBB conference to discuss the direction of the Center, its programs, and offer insights into ways the Center can best interact with industries through technology transfer. Board members also recommend topics for the annual conference, and sometimes serve as speakers.
| Advisory Board | |
| Board Members | Affiliation |
| Thomas Binder | President, ADM Research Division Archer Daniel Midland Company |
Lorenz Hasler |
Senior Project Evaluation Manager, Globial Biological Operations, Lonza AG |
| Mickey Wells | Director, Pharmaceutical Service, The University of Iowa |
| Debbie Yaver |
Director, Novozymes, Inc. |
| Past Board Members | Affiliation - current at time of posting and may not reflect their current position/affiliation |
| Douglas Cameron | Chief Scientist, Biotechnology Development Center, Cargill Inc. |
| Arnold Demain | Charles A Dana Research Institute, Drew University, National Academy of SciencesMember |
| Robert DiCosimo | Senior Research Fellow, DuPont Central Research and Development |
| Randolph Greasham | Director of Process Research, Merck |
| Steven J. Gould | Chief Scientific Officer, Mera Pharmaceuticals |
| T. Kent Kirk | Forest Products Fed Res. Labs, Dept Bacteriology, University of Wisconsin, Madison, Member National Academy of Sciences |
| Hans Leuenberger | Deputy Director, Central Research, Hoffmann LaRoche |
| Ashwin Madia | Vice President for Biotechnology research, Cargill |
| Barry Marrs | Director of Biotechnology, Hercules |
| Ellen L. McCormick | Director, Pfizer Global Biologics |
| Saul Neidleman | Neidleman Consulting |
| Peder Holk Nielsen | Corporate Vice president for Enzyme Development & Industrial Biotechnology, Novo Nordisk |
| Ramesh N. Patel | Process Research and Development, Bristol Myers Squibb |
| Nancy Platt | Vice President for Research, Pioneer HiBred |
| Rolland Poust | Director, Pharmaceutical Service, The University of Iowa |
| Karl Sanford | Vice President for Technology Development, Genencor International |
| Jim Spain | Air Force Research Laboratory, MLQL, Tyndall Air Force Base |
| Mani Subramanian | Director, Biotechnology Division, Dow Chemical Company |
| Tim Tressel | Director, Process and Analytical Sciences, Amgen, Inc. |
| Susan Truesdell | Central Research and Development, Pfizer Inc. |
| James F White | Senior Research Associate, Engelhard Corporation |
| Gregg Whited | Genencor International |
| Vincent Witterholt | Fellow and Distinguished Scientist, DuPont |
| Milton Zmijewski | Head, Biocatalysis Research, Eli Lilly |